Marking vaccine

Details Marking vaccine Marking vaccine

1977-11-04

1979-05-01

Fagelson, Anna P.

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

Molecular bilayer structure

128316, 424 8, 424 9, 424 12, 424 88, 424 92, 424 93, 424125, A61D 102, A61D 700, A61K 3910

Patent

active

041524128

ABSTRACT:
A vaccine, toxoid or like agent is administered to an animal by injecting the agent (usually intracutaneously) on a physiologically acceptable colored particle, preferably activated charcoal, which has a particle size whereby the colored particle remains at the point of injection to provide a visible mark which evidences administration of the vaccine or toxoid, and a repository of immunologically active material to serve as a booster.

REFERENCES:
patent: 2143088 (1939-01-01), Rockwell
patent: 2496270 (1950-02-01), Coler
patent: 2952585 (1960-09-01), Heller
patent: 3096249 (1963-07-01), Prigal
patent: 3097141 (1963-07-01), Wilcox
patent: 3379176 (1968-04-01), Propst
patent: 3633584 (1972-01-01), Farrell
Birkhaug AJCP, vol. 17, 1947, pp. 751-754.
Rosenthal, JAMA, vol. 177, Aug. 12, 1961, pp. 196-198, 452-454.

Affiliated with

Also associated with

Rating

Marking vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Marking vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Marking vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-631631